Nchi: Ayalandi
Lugha: Kiingereza
Chanzo: HPRA (Health Products Regulatory Authority)
LATANOPROST
Pfizer Healthcare Ireland
LATANOPROST
50 Microgram/ML
Eye Drops Solution
Product subject to prescription which may not be renewed (A)
Authorised
0000-00-00
PFB PIL IE d LP 009 Page 1 2013-0003455 PACKAGE LEAFLET: INFORMATION FOR THE USER LATANOPROST PFIZER 50 MICROGRAMS/ML EYE DROPS, SOLUTION Latanoprost READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. EVEN IF YOU HAVE ALREADY USED LATANOPROST PFIZER OR A SIMILAR MEDICINE BEFORE, WE ADVISE YOU TO READ THIS TEXT CAREFULLY. THE INFORMATION MAY HAVE BEEN CHANGED. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or the doctor treating your child or your pharmacist. • This medicine has been prescribed for you or for your child . Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or the doctor treating your child or your pharmacist. See section 4. IN THIS LEAFLET: 1. What Latanoprost Pfizer is and what it is used for 2. Before you use Latanoprost Pfizer 3. How to use Latanoprost Pfizer 4. Possible side effects 5. How to store Latanoprost Pfizer 6. Further information 1. WHAT LATANOPROST PFIZER IS AND WHAT IT IS USED FOR Latanoprost Pfizer belongs to a group of medicines known as prostaglandin analogues. It works by increasing the natural outflow of fluid from inside the eye into the bloodstream. Latanoprost Pfizer is used to treat conditions known as OPEN ANGLE GLAUCOMA and OCULAR HYPERTENSION in adults. Both of these conditions are linked with an increase in the pressure within your eye, eventually affecting your eye sight. PFB PIL IE d LP 009 Soma hati kamili
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Latanoprost Pfizer 50 Micrograms/ml eye drops, solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml of eye drops, solution contains 50 micrograms of latanoprost. 2.5 ml of eye drops, solution (content of a dropper container) contains 125 micrograms of latanoprost. One drop contains approximately 1.5 micrograms latanoprost. Excipient: 0.2 mg benzalkonium chloride/ml eye drops, solution is included as a preservative. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Eye drops, solution. The solution is a clear colourless liquid. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Reduction of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension. Reduction of elevated intraocular pressure in paediatric patients with elevated intraocular pressure and paediatric glaucoma. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Recommended dosage for adults (including the elderly):_ Recommended therapy is one eye drop in the affected eye(s) once daily. Optimal effect is obtained if Latanoprost Pfizer is administered in the evening. The dosage of Latanoprost Pfizer should not exceed once daily since it has been shown that more frequent administration decreases the intraocular pressure lowering effect. If one dose is missed, treatment should continue with the next dose as normal. As with any eye drops, to reduce possible systemic absorption, it is recommended that the lachrymal sac be compressed at the medial canthus (punctal occlusion) for one minute. This should be performed immediately following the instillation of each drop. Contact lenses should be removed before instillation of the eye drops and may be reinserted after 15 minutes. If more than one topical ophthalmic dru Soma hati kamili